← Eichor
Condition: Chronic Hepatitis B Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Chronic Hepatitis B

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04231565Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection
Phase N/A · 3 location(s) · Tam Anh Research Institute · NCT06638320HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
Phase 1 · 1 location(s) · Changhai Hospital · NCT06885710A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
Phase 2 · 1 location(s) · Ausper Biopharma Co., Ltd. · NCT07069569VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT06092333Research on Clinical Recovery and Maintenance Strategies for CHB
NA · 1 location(s) · Beijing Municipal Administration of Hospitals · NCT06803368Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
Phase N/A · 1 location(s) · Huashan Hospital · NCT04896255TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
Phase 1 · 1 location(s) · University of Maryland, Baltimore · NCT04843852Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
Phase 1 · 1 location(s) · Aarhus University Hospital · NCT06668727Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT06779864Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Phase 4 · 1 location(s) · Taichung Veterans General Hospital · NCT03933384Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
Phase N/A · 1 location(s) · Taichung Veterans General Hospital · NCT05583006Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Phase 4 · 1 location(s) · Mercy Medical Center · NCT04588077A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
Phase N/A · 5 location(s) · Tongji Hospital · NCT06525909A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease
Phase N/A · 1 location(s) · Qin Ning · NCT05255978Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of D
Phase N/A · 2 location(s) · University of Oxford · NCT06658782Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT06216470A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults
Phase 1 · 1 location(s) · Chimivac INC · NCT07059403A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone
Phase 2 · 1 location(s) · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT06425341SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Phase 4 · 1 location(s) · Chinese University of Hong Kong · NCT06364930Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
Phase N/A · 18 location(s) · Arbutus Biopharma Corporation · NCT06277037A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
Phase 1 · 2 location(s) · Ausper Biopharma Co., Ltd. · NCT07511218Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
NA · 1 location(s) · Qing XIe · NCT06323681Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic H
Phase N/A · 1 location(s) · Minghui Li · NCT06696664A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Phase 3 · 1 location(s) · Beijing Continent Pharmaceutical Co, Ltd. · NCT07343778Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare
NA · 2 location(s) · Institute of Gastroenterology and Hepatology, Vietnam · NCT07540637Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
Phase 4 · 1 location(s) · Humanity & Health Medical Group Limited · NCT03792919TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
Phase 1/Phase 2 · 6 location(s) · Michael Hoelscher · NCT06513286Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
Phase N/A · 3 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT06966908
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.